Join In The Know Cooking Contributor Joey Skladany each week as he goes live to show you this week's recipe highlight.
Join In The Know Cooking Contributor Joey Skladany each week as he goes live to show you this week's recipe highlight.
The "Wastewater Treatment Services - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
After a night of violence in Jerusalem, Israeli police made over 50 arrests and Palestinian medics said 100 were injured during Ramadan clashes in the contested city at the core of the Israeli-Palestinian conflict. From late Thursday night into early Friday, police in riot gear and on horseback fought to keep apart two groups of protesters - Palestinian youth hurling firecrackers and setting fire to dumpsters, and ultra-nationalist Israelis chanting anti-Arab slogans. Police deployed armoured vehicles spraying foul-smelling skunk water towards the two groups of protesters - Palestinians gathered around Jerusalem’s historic Damascus Gate and hundreds of right-wing Israelis several hundred metres away.
The "Smart Coatings - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
JPMorgan said on Friday it regretted supporting soccer clubs in launching a breakaway European Super League after the plan collapsed earlier this week amid intense criticism from fans and politicians. "We clearly misjudged how this deal would be viewed by the wider football community and how it might impact them in the future," a representative for the bank said. JPMorgan provided a 3.5 billion euro ($4.2 billion) grant to the founding clubs to spend on infrastructure and recovery from the impact of the COVID-19 pandemic.
The "Pulse Oximeters and Spirometers Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.
HMS Networks AB (publ) held its Annual General Meeting on April 23, 2021. In light of the ongoing corona pandemic and in order to minimize any risk of spreading of the corona virus, the Annual General Meeting was held only through postal voting in accordance with temporary legislation. The Meeting resolved in favour of all matters in accordance with the proposals of the Board of Directors and the Nomination Committee. The main contents of the most important resolutions are described below. Allocation of earningsThe Annual General Meeting resolved to approve the Board's proposed dividend of SEK 2.00 per share. The record date for the dividend was set to be April 27, 2021. The dividend is expected to be distributed by Euroclear Sweden on April 30, 2021. Adoption of the income statement and balance sheet and discharge from liabilityThe Annual General Meeting resolved to adopt the income statement and balance sheet for HMS Networks AB and the group as presented by the Board. The Board and the CEO were discharged from liability for the 2020 financial year. Election of Board members and auditors and determination of feesThe Annual General Meeting resolved in accordance with the Nominating Committee's proposals, namely: that six (6) Board members should be elected without any deputies,that one (1) registered public accounting firm should be elected as auditor,that the Board members Charlotte Brogren, Fredrik Hansson, Anders Mörck, Cecilia Wachtmeister, Ulf Södergren and Niklas Edling should be re-elected.that Charlotte Brogren should be re-elected as Chairman of the Board,that Öhrlings PricewaterhouseCoopers AB, with Johan Palmgren as auditor in charge, should be re-elected as auditor,that the fees to the Board members should amount to a total of SEK 1,875,000, of which SEK 625,000 should be paid to the Chairman of the Board and SEK 250,000 to each other Board member, and that fee for work in the Audit Committee should amount to SEK 100,000 to the Chairman and SEK 50,000 to each other member in the Audit Committee and that no fees should be paid for work in other committees. Board's remuneration report. The Annual General Meeting approved the Board's remuneration report. Authorisation of the Board to resolve on new share issuesThe Annual General Meeting resolved, in accordance with the Board's proposal, to authorise the Board to resolve on new share issues of maximum 2,340,943 shares in order to finance or carry out company acquisitions with the company’s own shares. Implementation of Share Saving Plan 2022-2025 and hedging activities to enable delivery of shares within the programThe Annual General Meeting resolved, in accordance with the Board's proposal, to implement a performance-based share saving plan, Share Saving Plan 2022-2025. The program is addressed to all employees and comprise a maximum of 100,000 shares. In order to enable the company’s delivery of shares to the participants in the program, the Annual General Meeting further resolved, in accordance with the Board’s proposal, to authorise the Board to repurchase a maximum of 100,000 of the company’s own shares and to transfer the repurchased shares to the participants in the program. For more information please contact: CEO Staffan Dahlström, phone: +46-35-17 29 01 CFO Joakim Nideborn, phone: +46-35-710 69 83 HMS Networks AB (publ) is a market-leading provider of solutions in industrial information and communication technology (Industrial ICT). HMS develops and manufactures products under the Anybus®, Ixxat®, Ewon® and Intesis® brands. Development takes place at the headquarter in Halmstad and also in Ravensburg, Nivelles, Igualada, Wetzlar Buchen and Delft. Local sales and support are handled by branch offices in Germany, USA, Japan, China, Singapore, Italy, France, Spain, the Netherlands, India, UK, Sweden, South Korea and UAE, as well as through a worldwide network of distributors and partners. HMS employs over 700 people and reported sales of SEK 1,467 million in 2020. HMS is listed on the NASDAQ OMX in Stockholm, category Mid Cap, Information Technology. Attachment PRM - HMS Networks Notice of AGM 2021
The "Conformal Coatings - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeNucleus Financial Group PLC(c) Name of the party to the offer with which exempt principal trader is connected:Nucleus Financial Group PLC(d) Date dealing undertaken:22 April 2021(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?No 2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a) Purchases and sales Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/receivedOrdinaryPurchases804185p185p (b) Derivatives transactions (other than options) Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit (ii) Exercising Class of relevant securityProduct description e.g. call optionNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable) The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. 3. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state “none” None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none” None Date of disclosure:23/04/2021Contact name:Molly AdkinTelephone number:020 7647 8154 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at firstname.lastname@example.org. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
(Bloomberg) -- The euro area’s economic recovery got fully underway in April with services returning to growth and manufacturing expanding at a record pace. Price pressures mounted as companies faced unprecedented delivery delays.Surveys of purchasing managers suggest that the 19-nation region is turning the page on the pandemic at the start of the second quarter, after on-and-off lockdowns dragged it into a double-dip recession.Euro-area services grew in April for the first time in eight months, a milestone for a sector that has been hamstrung by some of the worst restrictions since the outbreak, with many shops, hospitality and entertainment providers shut. The region’s manufacturing upturn, the strongest in more than two decades of data collection, continued to be led by Germany.New orders across both sectors rose to the highest level since 2018, and backlogs grew for a second month. Together with confidence at the highest level since data were first available in 2012, that led companies to continue to add jobs.“The euro-zone economy showed encouraging strength,” said Chris Williamson, an economist at IHS Markit. “Although the service sector continued to be hard hit by lockdown measures, it has returned to growth as companies adjust to life with the virus and prepare for better times ahead. The manufacturing sector is meanwhile booming.”While coronavirus infections continue to rise across the bloc, many businesses have learned to cope and an acceleration in vaccinations has fueled optimism that remaining restrictions can soon be lifted.The European Central Bank predicts the economy will expand in the second quarter, and President Christine Lagarde expressed confidence on Thursday that the region will see a “firm rebound” in the course of the year. She also promised to keep monetary stimulus abundant to keep financing conditions favorable for companies and households.“The ECB delivered incredibly good messages,” Agnes Belaisch, chief European strategist at Baring Investment Services, said on Bloomberg TV. Low inflation means policy makers won’t need to taper bond-buying, they’re focused on borrowing costs across all parts of the market, and risks to the outlook are balanced -- “which means, that whatever scars there are in the economy, and there are some, will not present headwinds to growth.”Still, over 1.5 million more people are unemployed than before the crisis, with millions more dependent on government furlough programs that could mean they still lose their jobs once support schemes expire. The economy isn’t expected to make up lost ground until the middle of 2022 -- a full year later than the U.S.Professional forecasters surveyed by the ECB lowered their growth outlook for the year to 4.2% from 4.4%, and raised their projection for next year to 4.1% from 3.7%.Factory prices are being boosted by a combination of the strong demand, delivery delays and the biggest jump in input costs in a decade. Prices charged rose at the fastest rate since early 2018, with increases for goods at an all-time high and those for services the biggest since the start of the pandemic.“Consumer-price inflation may well rise sharply in coming months as a result,” said Williamson, “though the extent of the rise will be dependent on the strength of demand and the supply situation, both of which remain highly uncertain at the moment.”The ECB said on Friday that its own conversations with non-financial companies have highlighted “increasing constraints” on their ability to respond to demand pressures. Manufacturers are being hit by a shortage of inputs -- most acutely semiconductors -- and transport bottlenecks that are pushing up costs. Businesses expect supply strains to worsen in the second quarter before gradually easing in the second half of the year.(Adds comment from strategist in eighth paragraph, ECB survey in 10th.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The right to shoot an elephant will cost trophy hunters between $10,000 and $70,000
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeGamesys Group plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure22/04/2021(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/AIf YES, specify which: OFFEROR Bally’s Corporation 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security:10p ordinary InterestsShort positionsNumber%Number%(1) Relevant securities owned and/or controlled: 51,808 0.0473 - 0(2) Cash-settled derivatives: 206,484 0.1884 - 0(3) Stock-settled derivatives (including options) and agreements to purchase/sell: - 0 - 0 TOTAL: 258,292 0.2356 - 0 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant securityPurchase/saleNumber of securitiesPrice per unit (b) Cash-settled derivative transactions Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit10p ordinaryEquity SwapsReducing a long position5,00019.2210p ordinaryEquity SwapsIncreasing a long position5,00019.2210p ordinaryEquity SwapsReducing a long position1,78019.19 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit (ii) Exercise Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” (c) Attachments Is a Supplemental Form 8 (Open Positions) attached?YES/NO Date of disclosure:23/04/2021Contact name:Abdi MusseTelephone number:+442071443164 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Value Based Care Payment Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the global value based care payment market as it emerges from the COVID-19 shut down. The value based care payment market reached a value of nearly $1,519.5 million in 2020, having increased at a compound annual growth rate (CAGR) of 3.9% since 2015. The market is expected to grow from $1,519.5 million in 2020 to $4,028.8 million in 2025 at a rate of 21.5%. The market is then expected to grow at a CAGR of 10.9% from 2025 and reach $6,768.0 million in 2030.Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.Create regional and country strategies on the basis of local data and analysis.Identify growth segments for investment.Outperform competitors using forecast data and the drivers and trends shaping the market.Understand customers based on the latest market research findings.Benchmark performance against key competitors.Utilize the relationships between key data sets for superior strategizing.Suitable for supporting your internal and external presentations with reliable high quality data and analysisReport will be updated with the latest data and delivered to you within 3-5 working days of order. Description:Where is the largest and fastest growing market for the value based care payment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The value based care payment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider value based care payment market, and compares it with other markets.The report covers the following chapters Executive Summary - The executive summary section of the report gives a brief overview and summary of the reportReport Structure - This section gives the structure of the report and the information covered in the various sections.Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by models, segmentation by deployment and segmentation by end-user.Market Characteristics - The market characteristics section of the report defines and explains the Value Based Care Payment market. This chapter also defines and describes goods and related services covered in the report.Trends and Strategies - This chapter describes the major trends shaping the global value based care payment market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.Impact of COVID-19 - This section describes the impact of COVID-19 on the value based care payment market.Global Market Size and Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.Segmentation - This section contains the market values (2015-2030) and analysis for different segments.Global Macro Comparison - The global value based care payment market comparison with macro-economic factors gives the Value Based Care Payment market size, percentage of GDP, and average Value Based Care Payment market expenditure.Regional Market Size and Growth - This section contains the region's market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.Competitive Landscape - This section covers details on the competitive landscape of the global value based care payment market, estimated market shares and company profiles for the leading players.Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.Market Opportunities and Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for value based care payment companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report. The global value based care payment market is segmented by country into Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia.Value-based care payment (VBCP) models are designed to reduce consumer spending on healthcare services while improving outcomes. VBCP models place greater accountability on clinical and cost outcome on institutions and individual healthcare professionals to deliver optimal care. The COVID-19 pandemic had profoundly affected the healthcare sector across the globe. The healthcare institutions on the front line of the crisis are focused on effective treatment and quick recovery of infected patients to reduce the burden on infrastructure throughout the pandemic. Non-frontline healthcare institutions observed a downfall in elective procedures and routine visits due to concerns over contraction of the virus. The above factors led to a slowdown in the shift towards value-based care from existing fee-for-service models.The value based care payment market is moderately fragmented, with large number of regional players operating in the market. The top 10 companies in the market occupied 25.26% of market share in the global value based care payment market. The key players in the value-based care payment market are focusing on expanding their product portfolio and operational presence in the sector through strategic acquisition of emerging and established companies in the industry. The top opportunities in the value based care payment market segmented by model will arise in the patient-centered medical home (PCMH) segment, which will gain $1,782.5 million of global annual sales by 2025. The top opportunities in the value based care payment market segmented by deployment will arise in the cloud based segment, which will gain $2,391.8 million of global annual sales by 2025. The top opportunities in the value based care payment market segmented by end-user will arise in the providers segment, which will gain $1,734.8 million of global annual sales by 2025. The value based care payment market size will gain the most in the USA at $1,343.0 million.Key Topics Covered: 1. Value Based Care Payment Market Executive Summary 2. Table of Contents 3. List of Figures 4. List of Tables 5. Report Structure 6. Introduction 6.1. Segmentation by Geography 6.2. Segmentation by Model 6.3. Segmentation by Deployment 6.4. Segmentation by End-User 7. Value Based Care Payment Market Characteristics 7.1. Market Definition 7.2. Segmentation by Model 7.3. Segmentation by Deployment 7.4. Segmentation by End-User 8. Value Based Care Payment Market Trends and Strategies 8.1. Increase in Bundle Payments 8.2. Collaborations and Partnerships 8.3. Remote Patient Monitoring As a Reimbursable Initiative for Valued Based Care 8.4. Increasing Adoption of Pay-for-Performance (P4P) Payment Model 8.5. Implementation of Optimal Care Management Strategy 9. Impact of COVID-19 on the Value Based Care Payment Market 9.1. Introduction 9.2. Short Term Effect of COVID-19 on Value-Based Care Payment Adoption 9.3. Long Term Effect of COVID-19 on Value-based Care Payment Adoption 9.4. Conclusion 10. Global Value Based Care Payment Market Size and Growth 10.1. Market Size 10.2. Historic Market Growth, 2015 - 2020, Value ($ Million) 10.3. Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million) 11. Global Value Based Care Payment Market Segmentation 11.1. Global Value Based Care Payment Market, Segmentation by Model11.2. Global Value Based Care Payment Market, Segmentation by Deployment11.3. Global Value Based Care Payment Market, Segmentation by End User12. Value Based Care Payment Market, Regional and Country Analysis 12.1. Global Value Based Care Payment Market, by Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million) 12.2. Global Value Based Care Payment Market, by Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million) 13. Asia-Pacific Value Based Care Payment Market 14. Western Europe Value Based Care Payment Market 15. Eastern Europe Value Based Care Payment Market 16. North America Value Based Care Payment Market 17. South America Value Based Care Payment Market 18. Middle East Value Based Care Payment Market 19. Africa Value Based Care Payment Market 20. Global Value Based Care Payment Market Competitive Landscape 20.1. Company Profiles 20.2. McKesson Corporation 20.2.1. Company Overview 20.2.2. Products and Services 20.2.3. Business Strategy 20.2.4. Financial Overview 20.3. Change Healthcare 20.3.1. Company Overview 20.3.2. Products and Services 20.3.3. Business Strategy 20.3.4. Financial Overview 20.4. Wipro Limited 20.4.1. Company Overview 20.4.2. Products and Services 20.4.3. Business Strategy 20.4.4. Financial Overview 20.5. nThrive, Inc. 20.5.1. Company Overview 20.5.2. Products and Services 20.5.3. Financial Overview 20.6. Premier Inc. 20.6.1. Company Overview 20.6.2. Products and Services 20.6.3. Business Strategy 20.6.4. Financial Overview 21. Key Mergers and Acquisitions in the Value Based Care Payment Market 21.1. W2O Acquired Discern Health 21.2. Siemens Medical Solutions Inc. Acquired ECG Management Consultants 21.3. Apervita Inc. Merged with Qcentive 21.4. Signify Health Merged with Remedy Partners 21.5. Veritas Capital Acquired Athenahealth 21.6. Veritas Capital Acquired Healthcare Technology Unit from General Electric (GE) 22. Value Based Care Payment Market Opportunities and Strategies 22.1. Global Value Based Care Payment Market in 2025 - Countries Offering most New Opportunities 22.2. Global Value Based Care Payment Market in 2025 - Segments Offering most New Opportunities 22.3. Global Value Based Care Payment Market in 2025 - Growth Strategies 22.3.1. Market Trend Based Strategies 22.3.2. Competitor Strategies 23. Value Based Care Payment Market, Conclusions and Recommendations 24. Appendix For more information about this report visit https://www.researchandmarkets.com/r/gm6vgp CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
In under a fortnight, Trevor Phillips’ daughter Sushila and Big Brother’s Nikki Grahame have died after battles with anorexia. The pandemic has caused four times the amount of people admitted to hospital for eating disorders and specialist clinics have two-year waiting lists, so what can be done? Rosie Fitzmaurice reports
‘We deserve the dignity of being known’: Teddy Cook’s transgender speech to NSW parliament praised. Health professional says he has been inundated with messages of support for speech opposing proposed law banning ‘gender fluidity’ promotions in schools
Climate change activists have dumped a pile of fake coal outside Lloyd’s of London in a protest against the fossil fuel industry. Extinction Rebellion protesters used a tipper truck to deposit the rubble outside the insurance giant. Demonstrators have accused Lloyd’s of underwriting polluting projects, such as tar sands and coal mines.
The "Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021" report has been added to ResearchAndMarkets.com's offering.
Una dose di vaccino anti-Covid di AstraZeneca o di Pfizer riduce il rischio di infezione di quasi due terzi, e protegge le persone anziane e più vulnerabili così come quelle più giovani e sane. E' quanto emerge da uno studio dell'università di Oxford e dell'Office for National Statistics britannico, condotto analizzando i risultati dei test Covid su oltre 350mila persone nel Regno Unito tra dicembre e aprile. Si tratta del "primo studio - si legge sul 'Guardian' - a valutare l'impatto" della prima dose "sulle nuove infezioni" da coronavirus Sars-CoV-2 "e le risposte immunitarie in un ampio gruppo di adulti nella popolazione generale. Riducendo i tassi di infezione, i vaccini non solo prevengono ricoveri e decessi, ma aiutano a spezzare le catene di trasmissione e quindi a ridurre il rischio di una recrudescenza dannosa della malattia a seguito della riapertura" in corso anche in Uk. I ricercatori hanno osservato che, a 21 giorni dalla prima somministrazione, le nuove infezioni Covid sono diminuite del 65%. I vaccini si sono dimostrati più efficaci contro le infezioni sintomatiche (-72%) rispetto a quelle asintomatiche (-57%). Un seconda dose di vaccino Pfizer, per il quale è possibile stimare l'effetto del richiamo essendo stato approvato e lanciato per primo rispetto a quello di AstraZeenca, ha ulteriormente potenziato la protezione, con una riduzione del 90% delle infezioni sintomatiche e del 70% di quelle asintomatiche. I risultati, diffusi oggi in versione preprint, secondo gli autori supportano la decisione del Regno Unito di dare priorità alla somministrazione di una prima dose di vaccino alle persone anziane e più vulnerabili, ritardando i richiami.
The Gunners icon claimed the fan channel has made the club a “laughing stock” due to viral videos following defeats
The ongoing second wave of the COVID-19 pandemic in India may decline steeply by the end of May, according to a mathematical module devised by IIT scientists.
It’s time to upgrade the fail-safe move